FT819 in Subjects With B-cell Malignancies
Fate Therapeutics
Fate Therapeutics
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
University of California, San Francisco
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Case Comprehensive Cancer Center
Sana Biotechnology
University of Maryland, Baltimore
Case Comprehensive Cancer Center
University Health Network, Toronto
Mayo Clinic
Cedars-Sinai Medical Center
Gilead Sciences
Fate Therapeutics
Bristol-Myers Squibb
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Gilead Sciences
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
M.D. Anderson Cancer Center
First Affiliated Hospital of Wenzhou Medical University
Hoffmann-La Roche
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
CTI BioPharma
AbbVie
M.D. Anderson Cancer Center